Alvelestat tosylate is an orally bioavailable, high-affinity, and selective inhibitor of neutrophil elastase (NE), used for the treatment of diseases involving excessive neutrophil elastase activity, such as chronic obstructive pulmonary disease (COPD), bronchiectasis, and other inflammatory lung conditions.